0001127602-23-030172.txt : 20231220
0001127602-23-030172.hdr.sgml : 20231220
20231220161812
ACCESSION NUMBER: 0001127602-23-030172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watson David O.
CENTRAL INDEX KEY: 0001657719
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 231501504
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-12-19
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657719
Watson David O.
C/O APELLIS PHARMACEUTICALS, INC
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
General Counsel
0
Common Stock
3333
I
Indirect Owner (Custodial Account for Son)
Common Stock
80705
I
Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Common Stock
6667
I
Indirect Owner (The Watson Education Trust)
Common Stock
2023-12-19
4
M
0
7905
13.85
A
93658
D
Common Stock
2023-12-19
4
S
0
1605
57.0041
D
92053
D
Common Stock
2023-12-19
4
S
0
2300
57.3827
D
89753
D
Stock Option (Right to Buy)
13.85
2023-12-19
4
M
0
7905
0
D
2029-02-07
Common Stock
7905
3762
D
This represents a custodial account held by the reporting person for the sole benefit of his minor son.
The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $56.290 - $57.280. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $57.300 - $57.830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on February 8, 2019
and is fully vested.
David Watson
2023-12-20